Valuation (97%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 8.79 | 16.31 |
| PEG Ratio (TTM) | 0.77 | -0.37 |
| P/S Ratio (TTM) | 1.15 | 2.62 |
| P/B Ratio (TTM) | 0.76 | 1.43 |
| P/FCF Ratio (TTM) | 0.75 | 6.20 |
| Price to 5YR AVG Earnings Ratio | 1.00 | 15.04 |
| Price to 5YR AVG FCF Ratio | 3.09 | 9.44 |
Profitability (25%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 0.72% | 0.94% |
| ROE (TTM) | 8.76% | 9.32% |
| Net Profit Margin (TTM) | 14.34% | 16.39% |
| ROIC 5YR AVG | 8.88% | 17.48% |
Growth (62%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | 36.72% | 16.19% | 1.36% |
| Revenue | 0.90% | 6.38% | 3.45% |
| Net Income | 36.89% | 16.14% | 1.43% |
| Cash Flow | -10.53% | 153.71% | 100.33% |
Health (39%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 2.44 | 12.43 |
| Quick Ratio (TTM) | 2.44 | 12.64 |
| D/E Ratio (TTM) | 2.32 | 1.04 |
| Interest Coverage (TTM) | 0.20 | 0.72 |
| Piotroski F-Score | 4 | 6 |
| Altman Z-Score | 0.56 | 0.43 |
| LTL to 5YR AVG FCF | 51.65 | 5.69 |
| Shares Outstanding Growth 5YR AVG | -0.09% | 57.94% |